Coagulation hemostasis
Conditions
Interventions
None listed
Sponsors
Vrije Universiteit Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients undergoing elective cardiothoracic surgery Age 18-90 years Preoperative hemoglobin of > 5.5 mmol/l Informed consent
Exclusion criteria
Exclusion criteria: Re-operations and emergency operations Use of erythropoietin Patients receiving blood transfusions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Level of comparison of ROTEM INTEM clotting time and aPTT (classical coagulation test) | — |
Secondary
| Measure | Time frame |
|---|---|
| Level of comparison of FIBTEM and Clauss test for fibrinogen. Demographic variables: Age, gender, length, body weight, preoperative and postoperative hematocrit, hemoglobin, leukocyte count. Surgical characteristics: Surgery time, clamp time, CPB time. Medicine use: use of drugs that influence coagulation Administration of blood products and fluid, urine production Comparison of treatment decision based on classical coagulation parameters and ROTEM analysis. | — |
Countries
Netherlands
Outcome results
None listed